Skip to main content
Ajooni Biotech Limited logo

Ajooni Biotech Limited — Investor Relations & Filings

Ticker · AJOONI ISIN · INE820Y01021 LEI · 335800OAKJWKHF49O339 National Stock Exchange of India Manufacturing
Open in API
Filings indexed 562 across all filing types
Latest filing 2021-09-29 Regulatory Filings
Country IN India
Listing National Stock Exchange of India AJOONI

About Ajooni Biotech Limited

https://www.ajoonibiotech.com

Ajooni Biotech Limited specializes in the production and distribution of animal healthcare solutions and nutritional supplements. The company focuses on the livestock sector, offering a comprehensive range of products including compounded cattle feed, mineral mixtures, and specialized supplements formulated to enhance milk productivity and overall animal health. Its portfolio features calcium supplements, liver tonics, and digestive aids designed to meet the specific nutritional needs of dairy animals. The company utilizes research-driven formulations and quality-controlled manufacturing processes to provide effective solutions for livestock management. By prioritizing animal welfare and productivity, it supports the operational efficiency of dairy farming through scientifically developed nutritional interventions.

Recent filings

Filing Released Lang Actions
Shareholders meeting
Regulatory Filings
2021-09-29 English
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a "Scrutinizer's Report on the Voting Results of 11th AGM held through Video Conferencing" for Ajooni Biotech Limited. It references the 11th Annual General Meeting (AGM) held on 27th September 2021 and details the voting results on various resolutions including ordinary and special resolutions. The report is prepared pursuant to Section 108 of the Companies Act, 2013 and related rules, and it consolidates votes cast remotely and at the e-AGM. The content is focused on the official voting results and the scrutiny process rather than the AGM presentation materials or the full annual report. This matches the definition of "Declaration of Voting Results & Voting Rights Announcements (DVA)" which covers official results from shareholder votes at any general meeting. The document length is substantial and contains detailed voting data, confirming it is not a brief announcement or a report publication notice. Therefore, the correct classification is DVA with high confidence.
2021-09-29 English
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed communication regarding the proceedings and outcome of the 11th Annual General Meeting (AGM) of Ajooni Biotech Limited held on September 27, 2021. It includes the agenda items discussed, such as adoption of audited financial statements, re-appointment of a director, approval of related party transactions, borrowing limits, alteration of the memorandum of association, and increase in authorized share capital. The document also mentions the voting process and the appointment of a scrutinizer for e-voting. The content is focused on the meeting's proceedings and resolutions passed, rather than the full annual report or financial statements themselves. This matches the definition of "Declaration of Voting Results & Voting Rights Announcements (DVA)" as it reports on the outcome of shareholder votes at the AGM. The document length (9091 characters) and detailed meeting summary support this classification rather than a brief announcement or a full annual report.
2021-09-27 English
Reply to Clarification- Financial results
Regulatory Filings Classification · 95% confidence The document is a letter from Ajooni Biotech Limited responding to a query from the National Stock Exchange of India regarding the format of financial results submitted. It references SEBI regulations and clarifies compliance with a specific SEBI circular. The document is short (998 characters) and does not contain actual financial data or detailed financial statements. It is a regulatory communication clarifying a submission format rather than the financial results themselves or a report. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents.
2021-09-16 English
Copy of Newspaper Publication
AGM Information Classification · 95% confidence The document is a detailed notice regarding the 11th Annual General Meeting (AGM) of Ajoont Biotech Limited. It includes information about the date and time of the AGM, e-voting procedures, book closure dates, and references to the Annual Report for the fiscal year 2020-21. The document also mentions compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and the Companies Act, 2013. It is primarily a notice and procedural communication related to the AGM rather than the full Annual Report itself. The document length is about 15,000 characters, which is substantial, but the content is focused on the AGM notice, e-voting instructions, and book closure details, not the full financial statements or management discussion. Therefore, this document fits the category of AGM Information (AGM-R).
2021-09-02 English
Reply to Clarification Sought
Board/Management Information Classification · 95% confidence The document is a letter addressed to the National Stock Exchange of India Ltd, dated 30/08/2021, from the company DNI Biotech Limited. It discusses the approval by the Board of Directors to alter the Object Clause of the Memorandum of Association, subject to shareholder approval at the upcoming Annual General Meeting. It also mentions an increase in the authorized share capital of the company. The content focuses on corporate governance matters, specifically changes to the company's constitutional documents and capital structure, rather than financial results or detailed reports. The document is not a full report but an announcement of board decisions and proposed changes requiring shareholder approval. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management and related corporate governance decisions. The document length (6615 characters) and content confirm it is not a brief report publication announcement or a regulatory filing. Hence, the classification is MANG with high confidence.
2021-08-31 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.